Suppr超能文献

抑制SULT2B1b表达会改变3β-羟基类固醇对人LNCaP前列腺癌细胞增殖和类固醇激素受体表达的影响。

Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.

作者信息

He Dongning, Falany Charles N

机构信息

Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

出版信息

Prostate. 2007 Sep 1;67(12):1318-29. doi: 10.1002/pros.20615.

Abstract

BACKGROUND

Sulfation is an important steroid inactivation in human tissues. Sulfotransferase (SULT) 2B1b selectively conjugates 3beta-hydroxysteroids and is expressed in epithelial cells of normal and cancerous prostate tissues. Dehydroepiandrosterone (DHEA) and Delta(5)-androstenediol (Delta(5)-Adiol) sulfation prevents their conversion to more potent androgens and estrogens in tissues although both compounds may also be biologically active.

METHODS

SULT2B1b expression and activity were inhibited >85% in human LNCaP prostate adenocarcinoma cells using short interference RNA (siRNA). The effects of treating control and SULT2B1b-deficient LNCaP cells with DHEA, Delta(5)-Adiol, and 5alpha-androstane-3beta-17beta-diol (Anstane-diol) on cellular proliferation, estrogen receptors (ERs), androgen receptor (AR), and prostate specific antigen protein levels were examined.

RESULTS

Physiological concentrations of DHEA and Delta(5)-Adiol increased proliferation of control cells and the proliferative effects were significantly increased in SULT2B1b-siRNA cells. DHEA, but not Delta(5)-Adiol increased AR levels at concentrations >/=1,000 nM in SULT2B1b-siRNA cells but not in control LNCaP cells. ER-alpha levels were not affected with any of the compounds tested. Physiological concentrations of DHEA and Delta(5)-A-diol decreased ER-beta levels in control cells and had significantly greater effects in SULT2B1b-siRNA cells. In contrast, Anstane-diol had no effect on AR or ER-alpha levels but induced more elevation of ER-beta levels in SULT2B1b-siRNA cells at concentrations >/=1,000 nM.

CONCLUSIONS

SULT2B1b is involved in regulating prostate cell responsiveness to DHEA and Delta(5)-Adiol. Inhibition of SULT2B1b increased cell proliferation and ER-beta repression after treatment with physiological levels of DHEA and Delta(5)-Adiol indicating that SULT2B1b has an inhibitory effect on DHEA and Delta(5)-Adiol activity.

摘要

背景

硫酸化是人体组织中一种重要的类固醇失活过程。硫酸转移酶(SULT)2B1b选择性地结合3β - 羟基类固醇,在正常和癌性前列腺组织的上皮细胞中表达。脱氢表雄酮(DHEA)和Δ⁵ - 雄烯二醇(Δ⁵ - Adiol)的硫酸化可防止它们在组织中转化为更强效的雄激素和雌激素,尽管这两种化合物也可能具有生物活性。

方法

使用小干扰RNA(siRNA)在人LNCaP前列腺腺癌细胞中抑制SULT2B1b的表达和活性>85%。研究了用DHEA、Δ⁵ - Adiol和5α - 雄甾烷 - 3β - 17β - 二醇(Anstane - diol)处理对照和SULT2B1b缺陷的LNCaP细胞对细胞增殖、雌激素受体(ERs)、雄激素受体(AR)和前列腺特异性抗原蛋白水平的影响。

结果

生理浓度的DHEA和Δ⁵ - Adiol增加了对照细胞的增殖,且在SULT2B1b - siRNA细胞中增殖作用显著增强。在SULT2B1b - siRNA细胞中,浓度≥1000 nM时,DHEA而非Δ⁵ - Adiol增加了AR水平,但在对照LNCaP细胞中未增加。所测试的任何化合物均未影响ER - α水平。生理浓度的DHEA和Δ⁵ - A - diol降低了对照细胞中的ER - β水平,且在SULT2B1b - siRNA细胞中的作用显著更大。相比之下,Anstane - diol对AR或ER - α水平无影响,但在浓度≥1000 nM时,在SULT2B1b - siRNA细胞中诱导ER - β水平升高更多。

结论

SULT2B1b参与调节前列腺细胞对DHEA和Δ⁵ - Adiol的反应性。用生理水平的DHEA和Δ⁵ - Adiol处理后,抑制SULT2B1b增加了细胞增殖和ER - β抑制,表明SULT2B1b对DHEA和Δ⁵ - Adiol活性具有抑制作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验